The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
About this Episode
Welcome to the Thoracic Oncology Group of Australasia Podcast series. In this Podcast, we discuss early NSCLC management and treatment, particularly in light of how immunotherapy will impact surgical and respiratory medicine as the landscape evolves with new data. Dr Melissa Moore Medical Oncologist from St Vincent’s Melbourne and the TOGA Education Chair, is joined by Dr Katharine See, Director and Head of the Respiratory Medicine at the Northern Hospital, Melbourne and Mr Naveed Alam, Thoracic surgeon from St Vincent’s and Epworth, Melbourne to discuss and review the findings and implications for NSCLC patients.
Thank you to Roche for collaborating on this podcast.